Test Price
2,800 AED✅ Home Collection Available
ST3GAL3 Gene (Autosomal Recessive Intellectual Disability Type 12) Genetic Test in UAE | 2,800 AED
Executive Summary – Clinical Confidence, Legally Compliant
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing, eliminating uncertainty.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across Dubai, Abu Dhabi, Sharjah, and all Northern Emirates.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by a DHA-licensed geneticist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 — instant pre‑approval for most UAE networks.
Test Overview & Methodology
The ST3GAL3 gene test identifies pathogenic variants responsible for autosomal recessive intellectual disability type 12, offering a definitive molecular diagnosis for unexplained neurological regression or developmental delay. The results enable neurologists and geneticists to tailor precise treatment and prognostic plans.
| Feature | Our Test (NGS Full Gene Sequencing) | Closest Alternative (Chromosomal Microarray) |
|---|---|---|
| Precision | Single‑nucleotide resolution; detects missense, nonsense, splice‑site, and small indels | Detects large deletions/duplications; misses most point mutations |
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq) with Sanger confirmation | Oligonucleotide array CGH |
| Turnaround Time | 3–4 Weeks (expedited option available) | 4–8 Weeks |
| Regulatory Compliance | DHA‑MOHAP approved; ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139); UAE PDPL | Variable; often lacks local genetic reporting standards |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403), advises: “This test provides powerful molecular insights, yet it is only one piece of the diagnostic puzzle. Results must be correlated with a comprehensive clinical evaluation—developmental history, neurological examination, and family pedigree—to avoid misinterpretation. Families should always proceed under the guidance of a multidisciplinary team including a neurologist and a clinical geneticist.”
Advisory: Medication and Clinical Guidance
Do not discontinue any prescribed medication—including antiepileptics or psychotropics—without explicit consultation with your treating physician. Always share test results with your specialist before adjusting therapy.
Safety Exclusion Criteria
This test is not indicated for asymptomatic individuals without a confirmed family history of intellectual disability. Prenatal testing requires separate DHA‑approved genetic counseling and informed consent. In cases of acute neurological deterioration, status epilepticus, or sudden loss of acquired skills, proceed immediately to the nearest emergency department—do not wait for test results.
Patient FAQ & Clinical Guidance
1. How accurate is the ST3GAL3 NGS test for diagnosing type 12 intellectual disability?
This test provides over 99.9% analytical sensitivity and specificity for sequence variants in the ST3GAL3 gene, making it the gold‑standard molecular confirmation for autosomal recessive intellectual disability type 12 when paired with clinical findings.
2. Will my insurance cover this genetic test in the UAE?
Most UAE insurers (Daman, Thiqa, Neuron, etc.) reimburse medically necessary single‑gene tests when prescribed by a DHA‑licensed neurologist and pre‑authorized through our dedicated WhatsApp line +971 54 548 8731 in under 60 minutes.
3. How is the sample collected and when will I get the result?
A simple blood draw (or one drop on FTA card) is performed at your home by a DHA‑certified phlebotomist using a temperature‑controlled transport kit. The final report is delivered within 3–4 weeks via secure email along with a tele‑consultation.
UAE Regulatory & Data Privacy Adherence
All personal health data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is licensed by the Dubai Health Authority (DHA Facility License Number: 1143) and holds ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | ST3GAL3 Gene (Autosomal Recessive Intellectual Disability Type 12) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (expedited option available) |
| Sample Type / Matrix | Peripheral whole blood or FTA card |
| Methodology Used | Next-Generation Sequencing (Illumina NovaSeq) with Sanger confirmation |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 82914-3 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians